The quinidine sulfate market share is expected to increase by USD 427.29 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.7%.
This quinidine sulfate market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers quinidine sulfate market segmentation by disease type (malaria and arrhythmias) and geography (North America, Europe, Asia, and Rest of World (ROW)). The quinidine sulfate market report also offers information on several market vendors, including Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. among others.
What will the Quinidine Sulfate Market Size be During the Forecast Period?

Download Report Sample to Unlock the Quinidine Sulfate Market Size for the Forecast Period and Other Important Statistics
Quinidine Sulfate Market: Key Drivers, Trends, and Challenges
The growing incidence of malaria is notably driving the quinidine sulfate market growth, although factors such as the emergence of insecticide-resistant vectors may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the quinidine sulfate industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Quinidine Sulfate Market Driver
- The growing incidence of malaria is one of the key drivers supporting the quinidine sulfate market growth.
- The growing incidence of malaria has increased the need for malaria rapid diagnostic devices, which can provide rapid test results and help in the diagnosis of the disease.
- According to WHO's latest world malaria report, there were an estimated 241 million malaria cases and 627,000 malaria deaths worldwide in 2020. This represented about 14 million more cases in 2020 compared with 2019 and 69,000 more deaths.
- According to a report published by the CDC in 2020, more than 219 million estimated cases of malaria were reported across the world. In addition, in the US, approximately 1,700 cases are diagnosed every year. Thus, to support and provide early diagnosis and treatment, the CDC provides information related to malaria through its CDC Division of Parasitic Diseases and Malaria diagnostic website, which is available 24 hours a day.
Key Quinidine Sulfate Market Trend
- Strong funding for the eradication of malaria is one of the key quinidine sulfate market trends contributing to the market growth.
- The funding for the control of malaria is increasing across the globe day by day as it is a life-threatening disease.
- The highest prevalence of malaria is in African countries, which is largely due to the poor sanitation levels and the insufficient fund to avail a healthy living. The underdeveloped healthcare infrastructure of these countries further restricts the eradication of malaria.
- To overcome the economic hurdle, various government and non-government organizations, such as Bill and Melinda Gates Foundation, and the World Bank, are conducting various awareness camps that are supported by strong funding. Such factors are expected to increase the demand for quinidine and, thereby, expected to drive the growth of the market in focus during the forecast period.
Key Quinidine Sulfate Market Challenge
- The emergence of insecticide-resistant vectors is one of the factors impeding the quinidine sulfate market growth.
- Malaria is a serious disease caused by a parasite of the Plasmodium species that commonly infects mosquitoes. When Anopheles mosquitoes feed on human blood, they transmit the parasite to their human hosts. Vector control remains one of the central components of malaria control.
- At present, only pyrethroids are approved for use in insecticide-treated nets, the most important malaria control intervention. However, insecticide resistance has emerged as one of the major challenges faced by the National Malaria Control Program in Africa.
- The resistance occurring in non-endemic areas also needs to be monitored because of the risk of vector migration to endemic regions. In the Advanced Molecular Detection (AMD) program carried out by the CDC, there are several genetic markers in Anopheles albimanus mosquitoes that are resistant to pyrethroid. Such an increase in the resistance to insecticides is expected to limit the growth of anti-malarial medicines, including quinidine sulfate, during the forecast period.
This quinidine sulfate market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global quinidine sulfate market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the quinidine sulfate market during the forecast period.
Who are the Major Quinidine Sulfate Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Bennet Pharmaceuticals Ltd.
- Buchler GmbH
- Cipla Ltd.
- Ipca Laboratories Ltd.
- Lark Laboratories India Ltd.
- Merck and Co. Inc.
- Merck KGaA
- PRISM INDUSTRIES LTD.
- Teva Pharmaceutical Industries Ltd.
- VIVAN Life Sciences Pvt. Ltd.
- Biophore India Pharmaceuticals Pvt. Ltd.
- Inga Laboratories P. Ltd.
- Koninklijke DSM NV
- PMC Group Inc.
- PT Bio Farma
- PT Sinkona Indonesia lestar
- Vital Laboratories Pvt. Ltd.
This statistical study of the quinidine sulfate market encompasses successful business strategies deployed by the key vendors. The quinidine sulfate market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Product Insights and News
- ipca.com - Under the unified segment, the company manufactures active pharmaceutical ingredients (APIs), generics, and branded formulations.
- ipca.com - The company offers quinidine sulfate products such as qinarsol tablets and injections.
To make the most of the opportunities and recover from post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The quinidine sulfate market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Quinidine Sulfate Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the quinidine sulfate market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Which are the Key Regions for Quinidine Sulfate Market?

For more insights on the market share of various regions Request PDF Sample now!
37% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the quinidine sulfate market in North America. Market growth in this region will be slower than the growth of the market in Asia.
The increasing funding for the development of anti-malarial medicines will facilitate the quinidine sulfate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 in 2020, which affected a large population in the region, boosted the demand for modification of anti-malarial drugs, including quinidine sulfate. Hence, the COVID-19 pandemic had a positive impact on the growth of the regional market, and it is expected to grow during the forecast period
What are the Revenue-generating Disease Type Segments in the Quinidine Sulfate Market?

To gain further insights on the market contribution of various segments Request PDF Sample
The quinidine sulfate market share growth in the malaria segment will be significant during the forecast period. Malaria is a life-threatening disease that is caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. Moreover, quinidine sulfate is used alone or with other medications to treat malaria in countries such as India and China where malaria is common. Thus, the rising prevalence of malaria, increase in malaria awareness programs, and initiatives by governments to control and prevent the prevalence of malaria across the globe are expected to increase the demand for quinidine sulfate during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the quinidine sulfate market size and actionable market insights on post-COVID-19 impact on each segment.
Quinidine Sulfate Market Scope
|
Report Coverage
|
Details
|
Page number
|
120
|
Base year
|
2021
|
Forecast period
|
2022-2026
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 6.7%
|
Market growth 2022-2026
|
$ 427.29 million
|
Market structure
|
Concentrated
|
YoY growth (%)
|
5.11
|
Regional analysis
|
North America, Europe, Asia, and Rest of World (ROW)
|
Performing market contribution
|
North America at 37%
|
Key consumer countries
|
US, Canada, Germany, UK, and China
|
Competitive landscape
|
Leading companies, Competitive strategies, Consumer engagement scope
|
Key companies profiled
|
Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd.
|
Market dynamics
|
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
|
Customization purview
|
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
|
Request PDF sample
What are the Key Data Covered in this Quinidine Sulfate Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive quinidine sulfate market growth during the next five years
- Precise estimation of the quinidine sulfate market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the quinidine sulfate industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of quinidine sulfate market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch